首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:International journal of rheumatology

缩写:

ISSN:1687-9260

e-ISSN:1687-9279

IF/分区:2.3/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引118
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Cheryl Barnabe,Peter D Faris,Hude Quan Cheryl Barnabe
Objective. To describe obstetrical and neonatal outcomes in Canadian women with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). Methods. An administrative database of hospitalizations for neonatal delivery (1998-2009) from ...
Toshiyuki Yamamoto,Ichiro Katayama Toshiyuki Yamamoto
Systemic sclerosis (SSc) is characterized by vascular injury, immunological abnormalities, and fibrosis of the skin as well as various internal organs. Vascular impairment is the early manifestation and plays a fundamental role in the patho...
Jessica Gordon,Robert Spiera Jessica Gordon
Tyrosine kinase inhibitors (TKIs) have emerged as a targeted therapy of interest for the treatment of systemic sclerosis (SSc). Recently, several groups have performed pilot or "proof-of-concept" studies to determine the feasibility of this...
Tamiko R Katsumoto,Shelia M Violette,Dean Sheppard Tamiko R Katsumoto
Interstitial lung disease (ILD) is a commonly encountered complication of systemic sclerosis (SSc) and accounts for a significant proportion of SSc-associated morbidity and mortality. Its pathogenesis remains poorly understood, and therapie...
Riccardo Chiusaroli,Tiziana Piepoli,Tiziano Zanelli et al. Riccardo Chiusaroli et al.
Several clinical studies demonstrated that glucosamine sulfate (GS) is effective in controlling osteoarthritis (OA), showing a structure-modifying action. However, little is known about the molecular mechanism(s) by which GS exerts such act...
Alessandra Pontillo,Nicola Di Toro,Paolo Edomi et al. Alessandra Pontillo et al.
Human glycolytic enzyme α-enolase was associated with human diseases and with inflammation. An ELISA test was developed to measure anti-α-enolase AAE IgG and AAE IgA in the serum from patients affected by inflammatory diseases with the pu...
M E Hettema,H Bootsma,R Graaff et al. M E Hettema et al.
Objective. To investigate whether advanced glycation endproducts (AGEs) in the skin are increased in patients with systemic sclerosis (SSc) and are related to the presence of disease-related and traditional cardiovascular risk factors. Meth...
Theresa C Barnes,Marina E Anderson,Robert J Moots Theresa C Barnes
Interleukin-6 is currently attracting significant interest as a potential therapeutic target in systemic sclerosis (SSc). In this paper, the biology of interleukin-6 is reviewed, and the evidence for interleukin-6 dysregulation in SSc is ex...
Tracy Frech,Kirsten Novak,Monica P Revelo et al. Tracy Frech et al.
Pruritus is a common symptom in systemic sclerosis (SSc), an autoimmune disease which causes fibrosis and vasculopathy in skin, lung, and gastrointestinal tract (GIT). Unfortunately, pruritus has limited treatment options in this disease. P...
Stéphane Chabaud,Véronique J Moulin Stéphane Chabaud
Diffuse systemic sclerosis (SSc) is a fatal autoimmune disease characterized by an excessive ECM deposition inducing a loss of function of skin and internal organs. Apoptosis is a key mechanism involved in all the stages of the disease: vas...